Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)

NCT05652712 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05652712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05652712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2019
Completion date
June 1, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer